Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women

Background. Previously we conducted a double-blind controlled, randomized efficacy field trial of gD-2 HSV vaccine adjuvanted with ASO4 in 8323 women. Subjects had been previously selected to be seronegative for HSV-1 and HSV-2. We found that vaccine was 82% protective against HSV-1 genital disease,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Belshe, Robert B., Heineman, Thomas C., Bernstein, David I., Bellamy, Abbie R., Ewell, Marian, van der Most, Robbert, Deal, Carolyn D.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
Major Articles and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3935479/
https://ncbi.nlm.nih.gov/pubmed/24285844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jit651
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars